+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • Report
  • March 2019
  • 164 Pages
  • Global
From
LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035 - Product Thumbnail Image

LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035

  • Report
  • April 2020
  • 80 Pages
  • Global
From
Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis - Product Thumbnail Image

Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis

  • Report
  • June 2023
  • 46 Pages
  • Global
From
N-Formyl Peptide Receptor 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

N-Formyl Peptide Receptor 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 32 Pages
  • Global
From
Heart Failure: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Heart Failure: Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 190 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • July 2026
  • 50 Pages
From
2024 Bristol-Myers Squibb Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

2024 Bristol-Myers Squibb Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • January 2025
  • Global
From
Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2026
  • 96 Pages
From
Bristol-Myers Squibb Company - Company Profile and SWOT Analysis - Product Thumbnail Image

Bristol-Myers Squibb Company - Company Profile and SWOT Analysis

  • SWOT Analysis
  • May 2025
  • 53 Pages
From
Comprehensive Report on Bristol-Myers Squibb, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Bristol-Myers Squibb, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator